X4 Pharmaceuticals (XFOR) came out with a quarterly loss of $0.69 per share versus the Zacks Consensus Estimate of a loss of $0.79. This compares to a loss of $5.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +12.66%. A quarter ago, it was expected that this company would post a loss of $4.53 per share when it actually produced a loss of $3.47, delivering a surprise of +23.4%.Over the last four quarters, the company has su ...

First Watch Restaurant Group, Inc. (FWRG) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -37.50%. A quarter ago, it was expected that this company would post earnings of $0.07 per share when it actually produced earnings of $0.03, delivering a surprise of -57.14%.Over the last four q ...

InterDigital (IDCC) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $1.79 per share. This compares to earnings of $1.63 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +42.46%. A quarter ago, it was expected that this wireless research and development company would post earnings of $3.36 per share when it actually produced earnings of $6.52, delivering a surprise of +94.05%.Over the ...

季度业绩表现 - 季度每股收益为255美元，超出市场共识预期的221美元，同比上年同期的188美元增长356% [1] - 季度营收达6401亿美元，超出市场共识预期839%，同比上年同期的5228亿美元增长224% [2] - 本季度业绩代表每股收益惊喜达1538%，而上一季度的收益惊喜为246% [1] - 公司在过去四个季度中四次超出每股收益共识预期，两次超出营收共识预期 [2] 股价表现与市场比较 - 公司股价自年初以来上涨约391%，同期标普500指数涨幅为172% [3] - 股价的近期走势可持续性将主要取决于管理层在财报电话会议中的评论 [3] 未来业绩展望与预期 - 当前市场对下一季度的共识每股收益预期为223美元，营收预期为6210亿美元 [7] - 当前财年的共识每股收益预期为945美元，营收预期为24900亿美元 [7] - 在本次财报发布前，对公司预期的修正趋势好坏参半 [6] 行业比较与同业情况 - 公司所属的医疗-牙科供应行业在Zacks行业排名中位列前21% [8] - 同业公司McKesson预计在截至2025年9月的季度每股收益为892美元，同比增长262% [9] - McKesson预计季度营收为10466亿美元，较上年同期增长118% [10] - McKesson的共识每股收益预期在过去30天内下调了0% [9]

财报业绩表现 - 2025年第三季度每股收益为1.72美元，超出市场一致预期1.69美元，同比去年同期的1.67美元增长，经调整后的盈利惊喜为+1.78% [1] - 上一季度每股收益为1.88美元，超出当时市场预期1.77美元，盈利惊喜达+6.21% [1] - 公司在过去四个季度均超出每股收益市场预期 [2] 营收表现与市场对比 - 2025年第三季度营收为7.683亿美元，低于市场一致预期0.82%，但较去年同期的7.253亿美元有所增长 [2] - 公司在过去四个季度中有三个季度营收超出市场预期 [2] - 公司股价年初至今下跌约15.7%，而同期标普500指数上涨17.2% [3] 未来业绩展望 - 当前市场对下一季度的共识预期为每股收益1.66美元，营收7.998亿美元 [7] - 当前市场对本财年的共识预期为每股收益6.98美元，营收31亿美元 [7] - 盈利预期修正趋势在财报发布前表现不一，公司当前Zacks评级为第3级（持有） [6] 行业信息 - 公司所属的Zacks行业分类为商业-信息服务行业，该行业在250多个Zacks行业中排名前30% [8] - 同行业公司uCloudlink Group Inc 预计将公布季度每股收益0.02美元，同比下降77.8%，预计营收为2210万美元，同比下降12.3% [9]

Automatic Data Processing (ADP) came out with quarterly earnings of $2.49 per share, beating the Zacks Consensus Estimate of $2.44 per share. This compares to earnings of $2.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +2.05%. A quarter ago, it was expected that this payroll and human resources company would post earnings of $2.22 per share when it actually produced earnings of $2.26, delivering a surprise of +1.8%.Over ...

Seagate (STX) came out with quarterly earnings of $2.61 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $1.58 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +10.59%. A quarter ago, it was expected that this electronic storage maker would post earnings of $2.46 per share when it actually produced earnings of $2.59, delivering a surprise of +5.28%.Over the last four quarters, the ...

股价表现与目标 - Business First (BFST) 在上一交易时段收于24.26美元，过去四周上涨2.4% [1] - 华尔街分析师设定的平均目标价为30.7美元，暗示有26.6%的上涨潜力 [1] - 五个短期目标价范围从30.00美元到32.00美元，最低估计意味着23.7%的涨幅，最乐观估计意味着31.9%的涨幅 [2] 分析师目标价分析 - 目标价的标准差为0.84美元，较低的标准差表明分析师之间的共识度较高 [2][9] - 分析师设定目标价的能力和公正性长期受到质疑 [3] - 研究表明目标价经常误导投资者，很少能准确预示股价实际走向 [7] - 分析师可能因所在机构与目标公司存在业务关系而设定过于乐观的目标价 [8] 盈利预期修正 - 分析师近期对公司的盈利前景越来越乐观，表现为一致上调每股收益（EPS）预期 [4][11] - 过去30天内，对本年度的盈利预期有两次上调，没有下调，因此Zacks共识预期上调了1.3% [12] - 盈利预期修正的趋势与短期股价变动存在强相关性 [11] 投资评级与结论 - BFST 目前拥有Zacks排名第2位（买入），这意味着其在基于盈利预期的4000多只股票中排名前20% [13] - 尽管共识目标价本身可能不可靠，但其暗示的股价运动方向似乎是一个良好的指引 [14]

Acadia Pharmaceuticals (ACAD) closed the last trading session at $22.99, gaining 7.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $29.35 indicates a 27.7% upside potential.The average comprises 20 short-term price targets ranging from a low of $17.00 to a high of $39.00, with a standard deviation of $5.55. While the lowest estimate indicates a decline of 26.1% from the current ...

季度业绩表现 - 季度每股收益为4.18美元，超出市场预期的4.13美元，同比增长19.4% [1] - 季度营收为35.6亿美元，略低于市场预期0.01%，但较去年同期的32.8亿美元增长8.5% [2] - 过去四个季度中，公司四次超出每股收益预期，两次超出营收预期 [2] 近期股价与市场展望 - 公司股价年初至今上涨20.2%，表现优于标普500指数16.9%的涨幅 [3] - 基于盈利预测修正的积极趋势，公司股票获得Zacks Rank 2（买入）评级，预计短期内将跑赢市场 [6] - 当前市场对下一季度的共识预期为每股收益4.03美元，营收35.8亿美元；对本财年的共识预期为每股收益16.30美元，营收140.2亿美元 [7] 行业背景与同业比较 - 公司所属的医疗服务行业在Zacks行业排名中位列前38%，研究表明排名前50%的行业表现优于后50%的行业，优势超过2比1 [8] - 同业公司LifeMD预计在即将公布的季度报告中将录得每股亏损0.06美元，同比改善57.1%，预计营收为6230万美元，同比增长16.7% [9]